Computer-aided Reverse Target Identification
Computer-aided reverse target identification is a critical step in drug discovery and drug repurposing. It aims to identify the core biological targets through which compounds exert their pharmacological effects, providing key insights for novel drug development and repurposing of existing agents.
Drug Repurposing
Identification of alternative disease-relevant targets
Off-target Prediction
Early-stage safety and selectivity assessment
Mechanism of Action Elucidation
Target deconvolution for phenotypic hits
Polypharmacology Profiling
Systematic multi-target interaction analysis
Applications
MCE integrates multiple state-of-the-art computational reverse target identification technologies, paired with an experienced platform for molecular interaction analysis, protein expression and purification. We offer comprehensive and customized one-stop solutions for target prediction, screening, and experimental validation.
AI-based Reverse Target Identification
AI-powered reverse target prediction uses small molecular structures as input and builds high-performance machine learning models trained on validated drug–target interaction data to accurately predict potential binding targets.
Based on algorithm optimization and intelligent high-dimensional data mining, this approach efficiently captures molecule–target binding patterns and greatly improves prediction accuracy and computational efficiency. The model supports continuous iterative optimization with large-scale experimental data and offers excellent interpretability, helping to elucidate the molecular mechanisms of drug action. It provides robust technical support for drug repurposing, natural product mechanism research, and innovative drug discovery.
Inverse Docking
Molecular docking–based reverse target identification screens potential targets by docking a query compound against a large-scale protein library in batch mode.
By evaluating binding affinity, conformational matching, and interaction patterns, it efficiently identifies high-affinity protein targets. This method requires no prior target information and combines high throughput and high reliability, providing a powerful strategy for drug repurposing and mechanism-of-action studies.
Service Advantages
• Provide comprehensive reverse target identification services using AI and molecular docking technologies.
• Possess an experienced platform for protein-protein interaction (PPI) analysis, protein expression and purification.
• High-performance computing servers guarantee rapid and efficient data processing.
• Professional team specializing in molecular simulation and drug design, backed by extensive industry experience.
• Rigorous data privacy management standards guarantee the information security.
Quote for Service
MCE - Inverse Target Identification Platform leverages advanced and diverse algorithms and computing capabilities to rapidly identify potential drug targets. It provides efficient and precise early-stage strategies for drug repurposing, mechanism analysis of natural product activities, novel drug discovery, as well as new applications of existing drugs. The platform significantly reduces the cost of experimental validation, accelerates the translation process from molecules to targets, and helps explore new directions for disease therapy.
For further information on service pricing, technical details and more, please send an email to [email protected] or contact the sales staff of MedChemExpress directly.